Entrada Therapeutics, Inc. (TRDA) (CIK 0001689375) CORRESP

Entrada Therapeutics, Inc. (TRDA) (CIK 0001689375) → SEC staff · filed 2025-12-01 · ticker TRDA · SIC 2834 · view PDF on sec.gov ↗
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

Key facts

Accession number
0001104659-25-117409
Form
CORRESP
Filer
Entrada Therapeutics, Inc. (TRDA) (CIK 0001689375)
CIK
0001689375
Ticker
TRDA
Filed
2025-12-01
SIC industry
2834
HQ
Boston, MA

Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1689375/000110465925117409/filename1.htm

EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗